✦ LIBER ✦

A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia

✍ Scribed by Tapan M. Kadia; Hui Yang; Alessandra Ferrajoli; Sirisha Maddipotti; Claudia Schroeder; Timothy L. Madden; Julianne L. Holleran; Merrill J. Egorin; Farhad Ravandi; Deborah A. Thomas; Willie Newsome; Blanca Sanchez-Gonzalez; James A. Zwiebel; Igor Espinoza-Delgado; Hagop M. Kantarjian; Guillermo Garcia-Manero

Book ID: 108676802
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 257 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08211.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Trial of Vorinostat Combined Wit

Phase I Trial of Vorinostat Combined With Bortezomib for the Treatment of Relapsing and/or Refractory Multiple Myeloma

✍ Donna M. Weber; Thorsten Graef; Mohamad Hussein; Ronald M. Sobecks; Gary J. Schi 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 279 KB

Phase I study of topotecan in combinatio

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours

✍ Hervé Rubie; Birgit Geoerger; Didier Frappaz; Antonin Schmitt; Pierre Leblond; A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Idarubicin in combination with intermedi

Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias

✍ Angelo M. Carella; Ester Pungolino; Gabriella Piatti; Eugenia Gaozza; Sandro Nat 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

High-dose idarubicin in combination with

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

✍ Alessandra Tedeschi; Marco Montillo; Elena Strocchi; Anna Maria Cafro; Elisabett 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 338 KB

Phase I and pharmacokinetic study of the

Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma

✍ Hidefumi WADA; Ryoji TSUBOI; Yukihiko KATO; Makoto SUGAYA; Kensei TOBINAI; Toshi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 236 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB